Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF STD & AIDS
Volume 29, Issue 5, Pages 443-452
Publisher
SAGE Publications
Online
2017-09-28
DOI
10.1177/0956462417732226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement in Insulin Sensitivity and Dyslipidemia in Protease Inhibitor-Treated Adult Male Patients After Switch to Atazanavir/Ritonavir
- (2016) Anthony J. Busti et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Impact of randomized antiretroviral therapy initiation on glucose metabolism
- (2014) Kristine Mace Erlandson et al. AIDS
- Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV
- (2014) Linda M. Nix et al. Current HIV/AIDS Reports
- A Comprehensive Review on Metabolic Syndrome
- (2014) Jaspinder Kaur Cardiology Research and Practice
- HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes
- (2013) Beth S. Zha et al. PLoS One
- Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
- (2012) Kathy Petoumenos et al. Journal of the International AIDS Society
- The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection
- (2011) Il Joon Paik et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular mechanisms for insulin resistance in treated HIV-infection
- (2011) Paul W. Hruz BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4
- (2011) Richard C. Hresko et al. PLoS One
- Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
- (2010) Reuben Granich et al. Current Opinion in HIV and AIDS
- HIV infection and the risk of diabetes mellitus
- (2009) Adeel A Butt et al. AIDS
- Metabolic syndrome associated with HIV and highly active antiretroviral therapy
- (2009) Giuseppe Barbaro et al. Current Diabetes Reports
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
- (2009) Andrew R. Zolopa et al. PLoS One
- Metabolic changes associated with antiretroviral therapy in HIV-positive patients
- (2009) Sabrina Esteves de Matos Almeida et al. REVISTA DE SAUDE PUBLICA
- HIV therapy, metabolic syndrome, and cardiovascular risk
- (2008) Vivian Pao et al. Current Atherosclerosis Reports
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
- (2008) S. De Wit et al. DIABETES CARE
- Metabolic Syndrome and Incident Diabetes: Current state of the evidence
- (2008) E. S. Ford et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now